var eventsData = [{"Ticker":"MYL","EffectiveDate":"2017-01-05","Type":"RatingNeutral","Title":"Citigroup downgrades MYL to Neutral from Buy. Target Price is $44; previously $59.","DailyReturn":"-1.18%","FiveDayReturnAfter":"-6.11%","FiveDayReturnBefore":"5.31%"},{"Ticker":"MYL","EffectiveDate":"2016-11-09","Type":"EarningsRevenueMiss","Title":"After market close, MYL reports 2016 Q3's earning $1.38 per share and revenue $3057MM. This misses analyst's estimated EPS $1.45, misses estimated revenue $3120MM.","DailyReturn":"4.87%","FiveDayReturnAfter":"4.09%","FiveDayReturnBefore":"-0.13%"},{"Ticker":"MYL","EffectiveDate":"2016-10-25","Type":"RatingNeutral","Title":"Mizuho initiates coverage on MYL to Buy.","DailyReturn":"2.98%","FiveDayReturnAfter":"-2.86%","FiveDayReturnBefore":"3.02%"},{"Ticker":"MYL","EffectiveDate":"2016-10-10","Type":"RatingUpgrade","Title":"Raymond James upgrades MYL to Strong Buy from Market Perform.","DailyReturn":"8.15%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"-5.88%"},{"Ticker":"MYL","EffectiveDate":"2016-09-30","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $45; previously $55.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-4.32%","FiveDayReturnBefore":"-10.17%"},{"Ticker":"MYL","EffectiveDate":"2016-09-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $58; previously $60.","DailyReturn":"-1.24%","FiveDayReturnAfter":"-10.17%","FiveDayReturnBefore":"2.61%"},{"Ticker":"MYL","EffectiveDate":"2016-08-15","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $55; previously $51.","DailyReturn":"0.59%","FiveDayReturnAfter":"0.41%","FiveDayReturnBefore":"0%"},{"Ticker":"MYL","EffectiveDate":"2016-08-09","Type":"EarningsBeatRevenueMiss","Title":"After market close, MYL reports 2016 Q2's earning $1.16 per share and revenue $2561MM. This beats analyst's estimated EPS $1.14, misses estimated revenue $2570MM.","DailyReturn":"2.86%","FiveDayReturnAfter":"0.45%","FiveDayReturnBefore":"3.75%"},{"Ticker":"MYL","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $51; previously $53.","DailyReturn":"-4%","FiveDayReturnAfter":"-6.81%","FiveDayReturnBefore":"-2.93%"},{"Ticker":"MYL","EffectiveDate":"2016-02-19","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on MYL to Market Perform.","DailyReturn":"1.4%","FiveDayReturnAfter":"5.88%","FiveDayReturnBefore":"-12.25%"},{"Ticker":"MYL","EffectiveDate":"2016-02-19","Type":"RatingNeutral","Title":"Argus Research maintains MYL to Buy. Target Price is $55; previously $65.","DailyReturn":"1.4%","FiveDayReturnAfter":"5.88%","FiveDayReturnBefore":"-12.25%"},{"Ticker":"MYL","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $50; previously $53.","DailyReturn":"3.15%","FiveDayReturnAfter":"11.24%","FiveDayReturnBefore":"-20.58%"},{"Ticker":"MYL","EffectiveDate":"2015-12-17","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy.","DailyReturn":"-2.61%","FiveDayReturnAfter":"0.73%","FiveDayReturnBefore":"7.02%"},{"Ticker":"MYL","EffectiveDate":"2015-12-03","Type":"RatingNeutral","Title":"Morgan Stanley assumes MYL to Equal-Weight. Target Price is $56.","DailyReturn":"-1.93%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"3.29%"},{"Ticker":"MYL","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $53; previously $60.","DailyReturn":"3.9%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"7.36%"},{"Ticker":"MYL","EffectiveDate":"2015-10-30","Type":"EarningsBeatRevenueMiss","Title":"After market close, MYL reports 2015 Q3's earning $1.43 per share and revenue $2712MM. This beats analyst's estimated EPS $1.38, misses estimated revenue $2780MM.","DailyReturn":"-3.69%","FiveDayReturnAfter":"-2.18%","FiveDayReturnBefore":"15.61%"},{"Ticker":"MYL","EffectiveDate":"2015-09-21","Type":"RatingNeutral","Title":"Barclays initiates coverage on MYL to Equal-Weight. Target Price is $57.","DailyReturn":"-2.88%","FiveDayReturnAfter":"-12.85%","FiveDayReturnBefore":"1.91%"},{"Ticker":"MYL","EffectiveDate":"2015-08-26","Type":"RatingNeutral","Title":"Standpoint Research initiates coverage on MYL to Buy. Target Price is $70.","DailyReturn":"4.11%","FiveDayReturnAfter":"-1.68%","FiveDayReturnBefore":"-12.68%"},{"Ticker":"MYL","EffectiveDate":"2015-07-27","Type":"RatingNeutral","Title":"Cowen & Co. downgrades MYL to Market Perform from Outperform.","DailyReturn":"-14.51%","FiveDayReturnAfter":"-16.35%","FiveDayReturnBefore":"-3.76%"},{"Ticker":"MYL","EffectiveDate":"2015-06-18","Type":"RatingNeutral","Title":"BTIG Research initiates coverage on MYL to Buy. Target Price is $85.","DailyReturn":"1.86%","FiveDayReturnAfter":"-0.52%","FiveDayReturnBefore":"-3.89%"},{"Ticker":"MYL","EffectiveDate":"2015-06-12","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $75.","DailyReturn":"-0.55%","FiveDayReturnAfter":"-2.11%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"MYL","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Raymond James initiates coverage on MYL to Market Perform.","DailyReturn":"0.15%","FiveDayReturnAfter":"2.08%","FiveDayReturnBefore":"2.42%"},{"Ticker":"MYL","EffectiveDate":"2015-04-22","Type":"RatingNeutral","Title":"CRT Capital maintains MYL to Buy. Target Price is $87; previously $68.","DailyReturn":"-2.25%","FiveDayReturnAfter":"-1.85%","FiveDayReturnBefore":"7.64%"},{"Ticker":"MYL","EffectiveDate":"2015-04-21","Type":"RatingUpgrade","Title":"BMO Capital upgrades MYL to Market Perform from Underperform. Target Price is $75; previously $41.","DailyReturn":"8.84%","FiveDayReturnAfter":"5.25%","FiveDayReturnBefore":"-0.74%"},{"Ticker":"MYL","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $65; previously $62.","DailyReturn":"-2.39%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"18.97%"},{"Ticker":"MYL","EffectiveDate":"2015-04-08","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $70; previously $66.","DailyReturn":"14.75%","FiveDayReturnAfter":"14.14%","FiveDayReturnBefore":"-0.71%"},{"Ticker":"MYL","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"CRT Capital maintains MYL to Buy. Target Price is $68; previously $60.","DailyReturn":"0.34%","FiveDayReturnAfter":"-2.29%","FiveDayReturnBefore":"5.37%"},{"Ticker":"MYL","EffectiveDate":"2015-03-06","Type":"RatingNeutral","Title":"Susquehanna maintains MYL to Positive. Target Price is $68; previously $60.","DailyReturn":"-2.2%","FiveDayReturnAfter":"9.43%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"MYL","EffectiveDate":"2015-03-05","Type":"RatingNeutral","Title":"Morgan Stanley assumes MYL to Overweight. Target Price is $67.","DailyReturn":"1.94%","FiveDayReturnAfter":"5.91%","FiveDayReturnBefore":"-1.58%"},{"Ticker":"MYL","EffectiveDate":"2015-01-15","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $62; previously $67.","DailyReturn":"-3.38%","FiveDayReturnAfter":"-0.27%","FiveDayReturnBefore":"-2.74%"},{"Ticker":"MYL","EffectiveDate":"2014-09-04","Type":"RatingNeutral","Title":"ISI Group initiates coverage on MYL.","DailyReturn":"-1.81%","FiveDayReturnAfter":"-0.77%","FiveDayReturnBefore":"-1.01%"},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $54; previously $57.","DailyReturn":"-1.37%","FiveDayReturnAfter":"-0.73%","FiveDayReturnBefore":"-6.01%"},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains MYL to Outperform. Target Price is $55; previously $60.","DailyReturn":"-1.37%","FiveDayReturnAfter":"-0.73%","FiveDayReturnBefore":"-6.01%"},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"RBC Capital downgrades MYL to Sector Perform from Outperform. Target Price is $53; previously $60.","DailyReturn":"-1.37%","FiveDayReturnAfter":"-0.73%","FiveDayReturnBefore":"-6.01%"},{"Ticker":"MYL","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Citigroup downgrades MYL to Neutral from Buy. Target Price is $57; previously $61.","DailyReturn":"-0.3%","FiveDayReturnAfter":"-4.99%","FiveDayReturnBefore":"0.9%"},{"Ticker":"MYL","EffectiveDate":"2014-07-15","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $68; previously $65.","DailyReturn":"1.81%","FiveDayReturnAfter":"0.29%","FiveDayReturnBefore":"1.33%"},{"Ticker":"MYL","EffectiveDate":"2014-06-11","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on MYL to Outperform.","DailyReturn":"0.93%","FiveDayReturnAfter":"2.96%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"MYL","EffectiveDate":"2014-05-05","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $57; previously $58.","DailyReturn":"0.14%","FiveDayReturnAfter":"-7.67%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"MYL","EffectiveDate":"2014-04-07","Type":"RatingUpgrade","Title":"Citigroup upgrades MYL to Buy from Neutral. Target Price is $61; previously $52.","DailyReturn":"-4.4%","FiveDayReturnAfter":"-10.2%","FiveDayReturnBefore":"3.61%"},{"Ticker":"MYL","EffectiveDate":"2014-04-04","Type":"RatingUpgrade","Title":"Citigroup upgrades MYL to Buy from Neutral.","DailyReturn":"1.54%","FiveDayReturnAfter":"-5.75%","FiveDayReturnBefore":"2.6%"},{"Ticker":"MYL","EffectiveDate":"2014-03-28","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $52; previously $42.","DailyReturn":"0.51%","FiveDayReturnAfter":"2.6%","FiveDayReturnBefore":"-7.96%"},{"Ticker":"MYL","EffectiveDate":"2014-02-28","Type":"RatingNeutral","Title":"Needham downgrades MYL to Hold from Buy. Target Price is $40.","DailyReturn":"-1.24%","FiveDayReturnAfter":"-3.12%","FiveDayReturnBefore":"7.39%"},{"Ticker":"MYL","EffectiveDate":"2014-02-27","Type":"EarningBeat","Title":"Before market open, MYL reports 2013 Q4's earning $0.78 per share and revenue $1810MM. This beats analyst's estimated EPS $0.75, meets estimated revenue $1810MM.","DailyReturn":"9.43%","FiveDayReturnAfter":"8.24%","FiveDayReturnBefore":"0.52%"},{"Ticker":"MYL","EffectiveDate":"2014-01-06","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on MYL to Outperform. Target Price is $50.","DailyReturn":"-1.07%","FiveDayReturnAfter":"7.33%","FiveDayReturnBefore":"-0.23%"},{"Ticker":"MYL","EffectiveDate":"2013-10-31","Type":"EarningsBeatRevenueMiss","Title":"Before market open, MYL reports 2013 Q3's earning $0.82 per share and revenue $1770MM. This beats analyst's estimated EPS $0.79, misses estimated revenue $1850MM.","DailyReturn":"-1.4%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"MYL","EffectiveDate":"2013-10-25","Type":"RatingNeutral","Title":"Citigroup initiates coverage on MYL to Neutral. Target Price is $42.","DailyReturn":"-0.15%","FiveDayReturnAfter":"-1.62%","FiveDayReturnBefore":"-3.12%"},{"Ticker":"MYL","EffectiveDate":"2013-10-14","Type":"RatingNeutral","Title":"Morgan Stanley downgrades MYL to Equal-weight from Overweight; previously $41.","DailyReturn":"-1.07%","FiveDayReturnAfter":"-3.46%","FiveDayReturnBefore":"-0.84%"},{"Ticker":"MYL","EffectiveDate":"2013-09-12","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy. Target Price is $46; previously $40.","DailyReturn":"1.76%","FiveDayReturnAfter":"1.43%","FiveDayReturnBefore":"5.73%"},{"Ticker":"MYL","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Bernstein upgrades MYL to Outperform from Market Perform. Target Price is $44; previously $35.","DailyReturn":"4.79%","FiveDayReturnAfter":"6.52%","FiveDayReturnBefore":"3.2%"},{"Ticker":"MYL","EffectiveDate":"2013-08-05","Type":"RatingUpgrade","Title":"Buckingham Research upgrades MYL to Buy from Neutral.","DailyReturn":"1.31%","FiveDayReturnAfter":"2.14%","FiveDayReturnBefore":"8.51%"},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"UBS maintains MYL to Buy. Target Price is $39; previously $36.","DailyReturn":"7.12%","FiveDayReturnAfter":"8.64%","FiveDayReturnBefore":"4.17%"},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingUpgrade","Title":"Cowen & Co. upgrades MYL to Outperform from Market Perform. Target Price is $45; previously $29.","DailyReturn":"7.12%","FiveDayReturnAfter":"8.64%","FiveDayReturnBefore":"4.17%"},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"Needham downgrades MYL to Buy from Strong Buy. Target Price is $40; previously $33.","DailyReturn":"7.12%","FiveDayReturnAfter":"8.64%","FiveDayReturnBefore":"4.17%"},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades MYL to Overweight from Equal-Weight. Target Price is $41.","DailyReturn":"7.12%","FiveDayReturnAfter":"8.64%","FiveDayReturnBefore":"4.17%"},{"Ticker":"MYL","EffectiveDate":"2013-08-01","Type":"EarningsBeatRevenueMiss","Title":"Before market open, MYL reports 2013 Q2's earning $0.68 per share and revenue $1700MM. This beats analyst's estimated EPS $0.67, misses estimated revenue $1730MM.","DailyReturn":"1.25%","FiveDayReturnAfter":"9.97%","FiveDayReturnBefore":"3.57%"},{"Ticker":"MYL","EffectiveDate":"2013-06-05","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $38; previously $34.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.96%","FiveDayReturnBefore":"-5.72%"},{"Ticker":"MYL","EffectiveDate":"2013-05-10","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on MYL to Underperform. Target Price is $21.","DailyReturn":"1.29%","FiveDayReturnAfter":"4.77%","FiveDayReturnBefore":"1.51%"},{"Ticker":"MYL","EffectiveDate":"2013-05-02","Type":"RevenueBeat","Title":"After market close, MYL reports 2013 Q1's earning $0.62 per share and revenue $1630MM. This meets analyst's estimated EPS $0.62, misses estimated revenue $1690MM.","DailyReturn":"0.45%","FiveDayReturnAfter":"2.17%","FiveDayReturnBefore":"0.03%"},{"Ticker":"MYL","EffectiveDate":"2013-04-02","Type":"RatingNeutral","Title":"Canaccord Genuity maintains MYL to Hold. Target Price is $32; previously $33.","DailyReturn":"-0.34%","FiveDayReturnAfter":"-1.15%","FiveDayReturnBefore":"-3.82%"},{"Ticker":"MYL","EffectiveDate":"2013-03-25","Type":"RatingNeutral","Title":"Bernstein downgrades MYL to Market Perform from Outperform. Target Price is $33.","DailyReturn":"-1.84%","FiveDayReturnAfter":"-3.82%","FiveDayReturnBefore":"-2.15%"},{"Ticker":"MYL","EffectiveDate":"2013-03-11","Type":"RatingNeutral","Title":"Canaccord Genuity downgrades MYL to Hold from Buy. Target Price is $33.","DailyReturn":"0.13%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"2.07%"},{"Ticker":"MYL","EffectiveDate":"2013-03-04","Type":"RatingNeutral","Title":"Bank of America maintains MYL to Buy. Target Price is $34; previously $33.","DailyReturn":"2.09%","FiveDayReturnAfter":"2.07%","FiveDayReturnBefore":"3.79%"},{"Ticker":"MYL","EffectiveDate":"2013-02-28","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy. Target Price is $33; previously $32.","DailyReturn":"3.64%","FiveDayReturnAfter":"7.83%","FiveDayReturnBefore":"-0.48%"},{"Ticker":"MYL","EffectiveDate":"2013-02-27","Type":"EarningBeat","Title":"After market close, MYL reports 2012 Q4's earning $0.65 per share and revenue $1720MM. This beats analyst's estimated EPS $0.64, meets estimated revenue $1720MM.","DailyReturn":"0.84%","FiveDayReturnAfter":"8%","FiveDayReturnBefore":"-2.71%"},{"Ticker":"MYL","EffectiveDate":"2013-01-08","Type":"RatingNeutral","Title":"Morgan Stanley downgrades MYL to Equal-Weight from Overweight; previously $27.","DailyReturn":"-0.46%","FiveDayReturnAfter":"-1.33%","FiveDayReturnBefore":"3.61%"},{"Ticker":"MYL","EffectiveDate":"2012-11-28","Type":"RatingNeutral","Title":"Canaccord Genuity maintains MYL to Buy. Target Price is $31; previously $30.","DailyReturn":"-0.03%","FiveDayReturnAfter":"0.69%","FiveDayReturnBefore":"4.74%"},{"Ticker":"MYL","EffectiveDate":"2012-11-26","Type":"RatingNeutral","Title":"Bank of America initiates coverage on MYL to Overweight.","DailyReturn":"-0.44%","FiveDayReturnAfter":"0.25%","FiveDayReturnBefore":"6.12%"},{"Ticker":"MYL","EffectiveDate":"2012-11-16","Type":"RatingUpgrade","Title":"Leerink Swann upgrades MYL to Outperform from Market Perform.","DailyReturn":"0.15%","FiveDayReturnAfter":"6.12%","FiveDayReturnBefore":"-0.58%"},{"Ticker":"MYL","EffectiveDate":"2012-10-26","Type":"RatingUpgrade","Title":"Canaccord Genuity upgrades MYL to Buy from Hold. Target Price is $30; previously $25.","DailyReturn":"0.88%","FiveDayReturnAfter":"3.3%","FiveDayReturnBefore":"3.54%"},{"Ticker":"MYL","EffectiveDate":"2012-07-26","Type":"EarningsRevenueBeat","Title":"Before market open, MYL reports 2012 Q2's earning $0.6 per share and revenue $1690MM. This beats analyst's estimated EPS $0.55, beats estimated revenue $1660MM.","DailyReturn":"4.88%","FiveDayReturnAfter":"5.64%","FiveDayReturnBefore":"-3.88%"},{"Ticker":"MYL","EffectiveDate":"2012-06-07","Type":"RatingNeutral","Title":"Bank oferica maintains MYL to Buy. Target Price is $27; previously $26.","DailyReturn":"0.09%","FiveDayReturnAfter":"-2.41%","FiveDayReturnBefore":"-0.74%"},{"Ticker":"MYL","EffectiveDate":"2012-04-26","Type":"EarningsRelease","Title":"Before market open, MYL reports 2012 Q1's earning $0.3 per share and revenue $1583MM..","DailyReturn":"-0.31%","FiveDayReturnAfter":"-3.57%","FiveDayReturnBefore":"-1.38%"}];